CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
TriSol is developing a heart valve replacement system for treating tricuspid valve diseases, aiming to improve patient outcomes with a quicker and safer procedure. This innovative approach reduces recovery time and hospital stays compared to traditional surgeries.
About 17 million people die each year from cardiovascular diseases (CVDs), a number that is expected to grow to more than 23 million by 2030.
Of these deaths, an estimated 7.4 million were due to heart disease, including heart valve disease (HVD) such as tricuspid regurgitation (TR).
The golden standard methods for tricuspid valve diseases are standard open-heart surgery and transcatheter valve replacement.
However, high-risk interventions require long recovery time long in-hospital stays and ha…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
